Answers are grounded in this paper and cite their sources.
Case report reveals lenvatinib's potential to cause intraparenchymal hemorrhage in hepatocellular carcinoma, indicating treatment risks.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Memon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: